Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024

Philipp Lambach; Sheetal Silal; Alyssa N Sbarra; Natasha S Crowcroft; Kurt Frey; Matt Ferrari; Emilia Vynnycky; C Jessica E Metcalf; Amy K Winter; Laura Zimmerman; Mitsuki Koh; Meru Sheel; Sun-Young Kim; Patrick K Munywoki; Allison Portnoy; Rakesh Aggarwal; Habib Hasan Farooqui; Stefan Flasche; Alexandra B Hogan; Kathy Leung; William J Moss; Xuan-Yi Wang

doi:10.1016/j.vaccine.2024.126307

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024

Vaccine. 2024 Dec 2;42(26):126307. doi: 10.1016/j.vaccine.2024.126307. Epub 2024 Sep 14.

Authors

Philipp Lambach¹, Sheetal Silal², Alyssa N Sbarra³, Natasha S Crowcroft¹, Kurt Frey⁴, Matt Ferrari⁵, Emilia Vynnycky⁶, C Jessica E Metcalf⁷, Amy K Winter⁸, Laura Zimmerman⁹, Mitsuki Koh¹, Meru Sheel¹⁰, Sun-Young Kim¹¹, Patrick K Munywoki¹², Allison Portnoy¹³, Rakesh Aggarwal¹⁴, Habib Hasan Farooqui¹⁵, Stefan Flasche¹⁶, Alexandra B Hogan¹⁷, Kathy Leung¹⁸, William J Moss¹⁹, Xuan-Yi Wang²⁰

Affiliations

¹ Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
² Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
³ Johns Hopkins Bloomberg School of Public Health, Baltimore, United States. Electronic address: [email protected].
⁴ Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, United States.
⁵ Pennsylvania State University, State College, United States.
⁶ UKHSA, London, United Kingdom; London School of Hygiene & Tropical Medicine, London, United Kingdom.
⁷ Department of Ecology and Evolutionary Biology, Princeton University, Princeton, United States.
⁸ Department of Epidemiology and Biostatistics & Center for the Ecology of Infectious Diseases, University of Georgia, Athens, United States.
⁹ Centers for Disease Control and Prevention, Atlanta, United States.
¹⁰ School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
¹¹ Seoul National University, Seoul, South Korea.
¹² Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya.
¹³ Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States.
¹⁴ Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
¹⁵ College of Medicine, QU Health, Qatar University.
¹⁶ Centre for Global Health, Charite, Berlin, Germany.
¹⁷ School of Population Health, University of New South Wales, Sydney, Australia.
¹⁸ School of Public Health, The University of Hong Kong, Hong Kong SAR, China.
¹⁹ Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
²⁰ Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

PMID: 39276622
DOI: 10.1016/j.vaccine.2024.126307

Abstract

The World Health Organization's Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves to independently review and evaluate vaccine-related research to maximize the potential impact of vaccination programs. From 28 June - 1 July 2024, IVIR-AC was convened for an ad hoc meeting to discuss new evidence on criteria for rubella vaccine introduction and the risk of congenital rubella syndrome. This report summarizes background information on rubella virus transmission and the burden of congenital rubella syndrome, meeting structure and presentations, proceedings, and recommendations.

Keywords: Congenital rubella syndrome; IVIR-AC; RCV; Rubella.

MeSH terms

Advisory Committees*
Humans
Immunization Programs
Rubella Syndrome, Congenital / prevention & control
Rubella Vaccine* / administration & dosage
Rubella Vaccine* / immunology
Rubella virus / immunology
Rubella* / prevention & control
Vaccination / methods
World Health Organization*

Substances

Rubella Vaccine

Grants and funding

001/WHO_/World Health Organization/International